DynaMedex, an integrated clinical decision support solution from EBSCO Information Services and Micromedex by Merative, has been recognized in the KLAS 2026 Software and Services Report as the top-performing solution for clinical decision support in point-of-care disease reference.
EBSCO Information Services stated that this recognition marks the sixth time it has received a Best in KLAS award. The company noted that DynaMedex combines two prior Best in KLAS solutions, DynaMed and Micromedex, into a single platform intended to provide timely, peer-reviewed disease guidance alongside evidence-based drug information.
According to the announcement, DynaMed was recognized as Best in KLAS in 2021, 2022, 2024, and 2025, while Micromedex was recognized in 2023 and 2026. The company added that the KLAS recognition follows a recent announcement that Dyna AI for DynaMedex will soon integrate expanded drug content, including dosing and medication safety information from Micromedex, into the platform.
KLAS Research, an independent research company that evaluates health information technology products, publishes its Best in KLAS report annually based on feedback collected from thousands of providers over the past year. The rankings are positioned as an industry benchmark, reflecting direct input from provider organizations on vendor performance, outcomes, value delivery, and long-term support.
EBSCO Information Services stated that its repeated acknowledgement by KLAS reflects its continued focus on point-of-care decision-making and demand for rapid access to clinical information at the bedside. The company directed readers to additional information about DynaMedex and the Best in KLAS report.
Click here to read the original press release.
